IDEXX LABORATORIES INC /DE Interest Income (Expense), Nonoperating, Net
IDEXX LABORATORIES INC /DE (IDXX) reported Interest Income (Expense), Nonoperating, Net of -$4.98 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2024-10-31
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for the quarter ending 2024-09-30 was -$4.98M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for the quarter ending 2024-06-30 was -$4.75M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for the quarter ending 2024-03-31 was -$3.48M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for the quarter ending 2023-12-31 was -$5.63M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for fiscal 2023 was -$35.95M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for fiscal 2022 was -$38.79M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for fiscal 2021 was -$29.37M.
- IDEXX LABORATORIES INC /DE interest income (expense), nonoperating, net for fiscal 2020 was -$32.54M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | -$4.98M 10-Q · filed 2024-10-31 | -$9.73M derived: sum of 2 quarters · filed 2024-10-31 | -$13.21M 10-Q · filed 2024-10-31 | -$18.84M derived: sum of 4 quarters · filed 2024-10-31 | |
| 2024-06-30 | -$4.75M 10-Q · filed 2024-08-06 | -$8.22M 10-Q · filed 2024-08-06 | -$13.86M derived: sum of 3 quarters · filed 2024-08-06 | -$21.25M derived: sum of 4 quarters · filed 2024-10-31 | |
| 2024-03-31 | -$3.48M 10-Q · filed 2024-05-01 | -$9.11M derived: sum of 2 quarters · filed 2024-05-01 | -$16.50M derived: sum of 3 quarters · filed 2024-10-31 | -$26.72M derived: sum of 4 quarters · filed 2024-10-31 | |
| 2023-12-31 | -$5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$13.03M derived: sum of 2 quarters · filed 2024-10-31 | -$23.24M derived: sum of 3 quarters · filed 2024-10-31 | -$35.95M 10-K · filed 2024-02-22 | |
| 2023-09-30 | -$7.39M 10-Q · filed 2024-10-31 | -$17.61M derived: sum of 2 quarters · filed 2024-10-31 | -$30.32M 10-Q · filed 2024-10-31 | -$43.63M derived: sum of 4 quarters · filed 2024-10-31 | |
| 2023-06-30 | -$10.21M 10-Q · filed 2024-08-06 | -$22.93M 10-Q · filed 2024-08-06 | -$36.24M derived: sum of 3 quarters · filed 2024-08-06 | -$46.88M derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | -$12.71M 10-Q · filed 2024-05-01 | -$26.02M derived: sum of 2 quarters · filed 2024-05-01 | -$36.67M derived: sum of 3 quarters · filed 2024-05-01 | -$44.65M derived: sum of 4 quarters · filed 2024-05-01 | |
| 2022-12-31 | -$13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$23.96M derived: sum of 2 quarters · filed 2024-02-22 | -$31.94M derived: sum of 3 quarters · filed 2024-02-22 | -$38.79M 10-K · filed 2024-02-22 | |
| 2022-09-30 | -$10.64M 10-Q · filed 2023-11-01 | -$18.63M derived: sum of 2 quarters · filed 2023-11-01 | -$25.48M 10-Q · filed 2023-11-01 | -$32.79M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | -$7.98M 10-Q · filed 2023-08-01 | -$14.84M 10-Q · filed 2023-08-01 | -$22.14M derived: sum of 3 quarters · filed 2024-02-22 | -$29.16M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | -$6.85M 10-Q · filed 2023-05-02 | -$14.16M derived: sum of 2 quarters · filed 2024-02-22 | -$21.17M derived: sum of 3 quarters · filed 2024-02-22 | -$28.70M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | -$7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$14.32M derived: sum of 2 quarters · filed 2024-02-22 | -$21.84M derived: sum of 3 quarters · filed 2024-02-22 | -$29.37M 10-K · filed 2024-02-22 | |
| 2021-09-30 | -$7.01M 10-Q · filed 2022-11-01 | -$14.53M derived: sum of 2 quarters · filed 2022-11-01 | -$22.07M 10-Q · filed 2022-11-01 | -$29.73M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | -$7.52M 10-Q · filed 2022-08-02 | -$15.05M 10-Q · filed 2022-08-02 | -$22.71M derived: sum of 3 quarters · filed 2023-02-16 | -$30.61M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | -$7.53M 10-Q · filed 2022-05-04 | -$15.19M derived: sum of 2 quarters · filed 2023-02-16 | -$23.09M derived: sum of 3 quarters · filed 2023-02-16 | -$32.52M derived: sum of 4 quarters · filed 2023-02-16 | |
| 2020-12-31 | -$7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$15.56M derived: sum of 2 quarters · filed 2023-02-16 | -$24.99M derived: sum of 3 quarters · filed 2023-02-16 | -$32.54M 10-K · filed 2023-02-16 | |
| 2020-09-30 | -$7.90M 10-Q · filed 2021-11-02 | -$17.33M derived: sum of 2 quarters · filed 2021-11-02 | -$24.88M 10-Q · filed 2021-11-02 | -$32.01M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | -$9.43M 10-Q · filed 2021-07-30 | -$16.98M 10-Q · filed 2021-07-30 | -$24.10M derived: sum of 3 quarters · filed 2022-02-16 | -$31.11M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | -$7.55M 10-Q · filed 2021-05-04 | -$14.68M derived: sum of 2 quarters · filed 2022-02-16 | -$21.68M derived: sum of 3 quarters · filed 2022-02-16 | -$29.83M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | -$7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$14.13M derived: sum of 2 quarters · filed 2022-02-16 | -$22.28M derived: sum of 3 quarters · filed 2022-02-16 | -$30.63M 10-K · filed 2022-02-16 | |
| 2019-09-30 | -$7.00M 10-Q · filed 2020-10-29 | -$15.16M derived: sum of 2 quarters · filed 2020-10-29 | -$23.50M 10-Q · filed 2020-10-29 | -$31.80M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-06-30 | -$8.15M 10-Q · filed 2020-07-31 | -$16.50M 10-Q · filed 2020-07-31 | -$24.80M derived: sum of 3 quarters · filed 2021-02-12 | -$33.11M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-03-31 | -$8.35M 10-Q · filed 2020-04-30 | -$16.65M derived: sum of 2 quarters · filed 2021-02-12 | -$24.96M derived: sum of 3 quarters · filed 2021-02-12 | -$33.24M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2018-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$16.61M derived: sum of 2 quarters · filed 2021-02-12 | -$24.90M derived: sum of 3 quarters · filed 2021-02-12 | -$33.59M 10-K · filed 2021-02-12 | |
| 2018-09-30 | -$8.31M 10-Q · filed 2019-10-31 | -$16.60M derived: sum of 2 quarters · filed 2019-10-31 | -$25.29M 10-Q · filed 2019-10-31 | -$33.41M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-06-30 | -$8.29M 10-Q · filed 2019-08-01 | -$16.98M 10-Q · filed 2019-08-01 | -$25.10M derived: sum of 3 quarters · filed 2020-02-14 | -$33.47M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-03-31 | -$8.70M 10-Q · filed 2019-05-01 | -$16.82M derived: sum of 2 quarters · filed 2020-02-14 | -$25.18M derived: sum of 3 quarters · filed 2020-02-14 | -$33.16M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2017-12-31 | -$8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$16.49M derived: sum of 2 quarters · filed 2020-02-14 | -$24.46M derived: sum of 3 quarters · filed 2020-02-14 | -$31.97M 10-K · filed 2020-02-14 | |
| 2017-09-30 | -$8.36M 10-Q · filed 2018-11-01 | -$16.34M derived: sum of 2 quarters · filed 2018-11-01 | -$23.85M 10-Q · filed 2018-11-01 | -$30.55M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2017-06-30 | -$7.98M 10-Q · filed 2018-08-01 | -$15.48M 10-Q · filed 2018-08-01 | -$22.18M derived: sum of 3 quarters · filed 2019-02-15 | -$29.12M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2017-03-31 | -$7.51M 10-Q · filed 2018-05-04 | -$14.20M derived: sum of 2 quarters · filed 2019-02-15 | -$21.14M derived: sum of 3 quarters · filed 2019-02-15 | -$28.41M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2016-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$13.63M derived: sum of 2 quarters · filed 2019-02-15 | -$20.91M derived: sum of 3 quarters · filed 2019-02-15 | -$28.39M 10-K · filed 2019-02-15 | |
| 2016-09-30 | -$6.93M 10-Q · filed 2017-10-31 | -$14.21M derived: sum of 2 quarters · filed 2017-10-31 | -$21.70M 10-Q · filed 2017-10-31 | -$28.82M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-06-30 | -$7.28M 10-Q · filed 2017-08-01 | -$14.76M 10-Q · filed 2017-08-01 | -$21.89M derived: sum of 3 quarters · filed 2018-02-16 | -$28.95M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-03-31 | -$7.48M 10-Q · filed 2017-04-28 | -$14.61M derived: sum of 2 quarters · filed 2018-02-16 | -$21.68M derived: sum of 3 quarters · filed 2018-02-16 | -$28.38M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2015-12-31 | -$7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$14.19M derived: sum of 2 quarters · filed 2018-02-16 | -$20.89M derived: sum of 3 quarters · filed 2018-02-16 | -$26.77M 10-K · filed 2018-02-16 | |
| 2015-09-30 | -$7.07M 10-Q · filed 2016-11-01 | -$13.77M derived: sum of 2 quarters · filed 2016-11-01 | -$19.64M 10-Q · filed 2016-11-01 | -$24.58M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-06-30 | -$6.70M 10-Q · filed 2016-08-02 | -$12.58M 10-Q · filed 2016-08-02 | -$17.52M derived: sum of 3 quarters · filed 2017-02-17 | -$21.50M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-03-31 | -$5.88M 10-Q · filed 2016-04-29 | -$10.82M derived: sum of 2 quarters · filed 2017-02-17 | -$14.80M derived: sum of 3 quarters · filed 2017-02-17 | -$17.28M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2014-12-31 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$8.92M derived: sum of 2 quarters · filed 2017-02-17 | -$11.40M derived: sum of 3 quarters · filed 2017-02-17 | -$13.70M 10-K · filed 2017-02-17 | |
| 2014-09-30 | -$3.98M 10-Q · filed 2015-10-28 | -$6.46M derived: sum of 2 quarters · filed 2015-10-28 | -$8.76M 10-Q · filed 2015-10-28 | -$10.13M derived: sum of 4 quarters · filed 2016-02-17 | |
| 2014-06-30 | -$2.48M 10-Q · filed 2015-07-30 | -$4.78M 10-Q · filed 2015-07-30 | -$6.15M derived: sum of 3 quarters · filed 2016-02-17 | -$7.16M derived: sum of 4 quarters · filed 2016-02-17 | |
| 2014-03-31 | -$2.30M 10-Q · filed 2015-04-28 | -$3.67M derived: sum of 2 quarters · filed 2016-02-17 | -$4.68M derived: sum of 3 quarters · filed 2016-02-17 | -$5.41M derived: sum of 4 quarters · filed 2016-02-17 | |
| 2013-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | -$2.38M derived: sum of 2 quarters · filed 2016-02-17 | -$3.11M derived: sum of 3 quarters · filed 2016-02-17 | -$3.50M 10-K · filed 2016-02-17 | |
| 2013-09-30 | -$1.01M 10-Q · filed 2014-10-24 | -$1.74M derived: sum of 2 quarters · filed 2014-10-24 | -$2.13M 10-Q · filed 2014-10-24 | -$2.48M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-30 | -$735.00K 10-Q · filed 2014-07-25 | -$1.13M 10-Q · filed 2014-07-25 | -$1.47M derived: sum of 3 quarters · filed 2015-02-17 | -$1.87M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-31 | -$391.00K 10-Q · filed 2014-04-25 | -$734.00K derived: sum of 2 quarters · filed 2015-02-17 | -$1.13M derived: sum of 3 quarters · filed 2015-02-17 | -$1.58M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2012-12-31 | -$343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$743.00K derived: sum of 2 quarters · filed 2015-02-17 | -$1.19M derived: sum of 3 quarters · filed 2015-02-17 | -$1.95M 10-K · filed 2015-02-17 | |
| 2012-09-30 | -$400.00K 10-Q · filed 2013-10-22 | -$846.00K derived: sum of 2 quarters · filed 2013-10-22 | -$1.60M 10-Q · filed 2013-10-22 | -$2.21M derived: sum of 4 quarters · filed 2014-02-18 | |
| 2012-06-30 | -$446.00K 10-Q · filed 2013-07-23 | -$1.20M 10-Q · filed 2013-07-23 | -$1.81M derived: sum of 3 quarters · filed 2014-02-18 | -$2.28M derived: sum of 4 quarters · filed 2014-02-18 | |
| 2012-03-31 | -$757.00K 10-Q · filed 2013-04-23 | -$1.36M derived: sum of 2 quarters · filed 2014-02-18 | -$1.84M derived: sum of 3 quarters · filed 2014-02-18 | -$2.20M derived: sum of 4 quarters · filed 2014-02-18 | |
| 2011-12-31 | -$603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | -$1.08M derived: sum of 2 quarters · filed 2014-02-18 | -$1.44M derived: sum of 3 quarters · filed 2014-02-18 | -$1.80M 10-K · filed 2014-02-18 | $1.80M 10-K · filed 2012-02-17 |
| 2011-09-30 | -$478.00K 10-Q · filed 2012-10-19 | -$841.00K derived: sum of 2 quarters · filed 2012-10-19 | -$1.20M 10-Q · filed 2012-10-19 | -$1.54M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-06-30 | -$363.00K 10-Q · filed 2012-07-20 | -$722.00K 10-Q · filed 2012-07-20 | -$1.06M derived: sum of 3 quarters · filed 2013-02-19 | -$1.61M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-03-31 | -$359.00K 10-Q · filed 2012-04-20 | -$697.00K derived: sum of 2 quarters · filed 2013-02-19 | -$1.25M derived: sum of 3 quarters · filed 2013-02-19 | -$1.80M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2010-12-31 | -$338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$889.00K derived: sum of 2 quarters · filed 2013-02-19 | -$1.44M derived: sum of 3 quarters · filed 2013-02-19 | -$1.75M 10-K · filed 2013-02-19 | $1.75M 10-K · filed 2012-02-17 |
| 2010-09-30 | -$551.00K 10-Q · filed 2011-10-21 | -$1.10M derived: sum of 2 quarters · filed 2011-10-21 | -$1.41M 10-Q · filed 2011-10-21 | ||
| 2010-06-30 | -$551.00K 10-Q · filed 2011-07-22 | -$863.00K 10-Q · filed 2011-07-22 | |||
| 2009-12-31 | $1.43M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |